| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/21/2011 | WO2011047097A2 Inhibition of trem receptor signaling with peptide variants |
| 04/21/2011 | WO2010115080A3 Self-assembling peptides bearing organic electronic functionality and applications employing the same |
| 04/21/2011 | US20110092671 Peptide manufacturing process |
| 04/21/2011 | US20110092668 Azide functionalized peptide targeting groups |
| 04/21/2011 | US20110092448 Peptide Conjugate for Oral Delivery of Hydrophilic Peptide Analgesics |
| 04/21/2011 | US20110092431 Skin aging-inhibiting peptide |
| 04/21/2011 | US20110092384 Compositions and methods for producing coded peptoid libraries |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/20/2011 | EP2312318A1 Prion protein ligands and methods of use |
| 04/20/2011 | EP2311992A1 Method for rapid detection and identification of bioagents |
| 04/20/2011 | EP2311852A1 Anti-infarction molecules |
| 04/20/2011 | EP2311851A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/20/2011 | EP2311850A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/20/2011 | EP2311849A1 Specific binding agents of human angiopoietin-2 |
| 04/20/2011 | EP2311469A2 Methods and compositions for tissue regeneration |
| 04/20/2011 | EP2310402A1 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 04/20/2011 | EP2310095A1 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | EP1325024B1 Selective growth media |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102020700A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/20/2011 | CN102020699A Anti-platelet aggregation peptide and application thereof |
| 04/20/2011 | CN102020698A Hepatitis c virus protease inhibitor |
| 04/20/2011 | CN102020697A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 04/20/2011 | CN101445550B Synthetic method of pyroglutamyl small peptide |
| 04/19/2011 | US7928186 Cell permeable bioactive peptide conjugates |
| 04/19/2011 | US7928185 Synthetic arginine substituted peptides and their use |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7927581 Peptide-based multimeric targeted contrast agents |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2320429C Antimicrobial peptides and derived metapeptides |
| 04/14/2011 | US20110086416 Immunotoxin fusion proteins and means for expression thereof |
| 04/14/2011 | US20110086006 HCV NS3-NS4 Protease Resistance Mutants |
| 04/13/2011 | EP1575605B1 Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser |
| 04/13/2011 | CN102016061A Novel peptidase substrates |
| 04/13/2011 | CN102015764A Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 04/13/2011 | CN102010425A 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 04/07/2011 | WO2011041551A1 Therapeutic antiviral peptides |
| 04/07/2011 | US20110082282 Process of preparing conjugates of allium organosulfur compounds with amino acids, peptides, and proteins |
| 04/07/2011 | US20110082281 Casein hydrolyzate, process for producing the same and use thereof |
| 04/07/2011 | US20110081371 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/07/2011 | US20110081293 Methods and compositions related to clot-binding lipid compounds |
| 04/06/2011 | EP2305698A2 Macrocyclic inhibitors of Hepatitis C virus replication |
| 04/06/2011 | EP2305697A2 Macrocyclic inhibitors of Hepatitis C virus replication |
| 04/06/2011 | EP2305696A2 Macrocyclic inhibitors of Hepatitis C virus replication |
| 04/06/2011 | EP2305695A2 Macrocyclic inhibitors of Hepatitis C virus replication |
| 04/06/2011 | EP2303910A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 04/06/2011 | EP2303030A1 Lactobacillus helveticus strains for producing hypotensive peptides |
| 04/06/2011 | EP1404356B1 Method for designing cd10-activated prodrug compounds |
| 04/06/2011 | CN102007217A Enzymatic conjugation of bioactive moieties |
| 04/06/2011 | CN102002004A Taltirelin intermediate and synchronizing method of taltirelin |
| 04/05/2011 | US7919576 Immunogenic CD19 peptides |
| 04/05/2011 | US7919469 Methods and compositions for altering mucus secretion |
| 04/05/2011 | US7919468 Compounds useful as modulators of the proteasome activity |
| 04/05/2011 | US7919454 Methods of treating using conjugates transported by a PEPT2 transporter |
| 04/05/2011 | US7919076 PH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 04/05/2011 | US7919071 Contrast agent |
| 04/05/2011 | CA2437788C Inflammation-inhibiting compounds |
| 04/05/2011 | CA2284547C Mu-opiate receptor peptides |
| 03/31/2011 | WO2011038293A1 Cyclic peptide inhibitors of hepatitis c virus replication |
| 03/31/2011 | WO2011038283A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/31/2011 | WO2011036457A1 Peptide clearing agents |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110076246 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| 03/31/2011 | CA2775697A1 Cyclic peptide inhibitors of hepatitis c virus replication |
| 03/31/2011 | CA2774387A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/31/2011 | CA2774081A1 Peptide clearing agents |
| 03/30/2011 | EP2302391A1 Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis |
| 03/30/2011 | EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus |
| 03/30/2011 | EP2301951A1 Peptide derivative and composition for promoting tear secretion comprising the same |
| 03/30/2011 | EP2301581A1 Production and use of novel peptide-based agents for use with B1-specific antibodies |
| 03/30/2011 | EP2301563A2 HSP20 peptides |
| 03/30/2011 | EP2300491A1 Hepatitis c virus inhibitors |
| 03/30/2011 | EP2300490A1 Hepatitis c virus inhibitors |
| 03/30/2011 | EP1506172B1 Hepatitis c virus inhibitors |
| 03/30/2011 | CN1906208B Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
| 03/30/2011 | CN101993473A Polypeptide glaucocalyxin A derivatives as well as preparation method and application thereof |
| 03/29/2011 | US7915291 Hepatitis C virus inhibitors |
| 03/29/2011 | US7915224 Method of preparing peptide |
| 03/29/2011 | US7915223 Antimicrobial agents |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | US7914780 Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
| 03/29/2011 | US7914778 Methods of treatment using IL-16 antagonist peptides |
| 03/29/2011 | CA2435146C Formulation of boronic acid compounds |
| 03/29/2011 | CA2407514C Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 03/24/2011 | WO2011034659A2 Advantageous mu-opiate receptor peptide compounds |
| 03/24/2011 | WO2010052715A3 Implantable medical devices for the treatment of cardiovascular di seases |
| 03/24/2011 | US20110071084 Benzazepine derivatives useful as vasopressin antagonists |
| 03/24/2011 | US20110071082 Long lasting anti-angiogenic peptides |
| 03/24/2011 | US20110070276 Bioactive keratin peptides |
| 03/24/2011 | US20110070168 Macrocyclic peptides as inhibitors of viral replication |
| 03/24/2011 | US20110070155 Anti-CD74 Immunoconjugates and Methods |
| 03/24/2011 | CA2772968A1 Advantageous mu-opiate receptor peptide compounds |
| 03/23/2011 | EP2299271A2 Kokumi-imparting agent |
| 03/23/2011 | EP2297178A2 Peptide analogs of alpha-melanocyte stimulating hormone |